Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Nucera, Carmelo
Item TypeName
Academic Article Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules.
Academic Article Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.
Academic Article Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.
Academic Article A novel orthotopic mouse model of human anaplastic thyroid carcinoma.
Academic Article Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).
Academic Article The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
Academic Article Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer.
Academic Article BRAF(V600E) mutation and the biology of papillary thyroid cancer.
Academic Article BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression.
Academic Article B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression.
Concept Proto-Oncogene Proteins B-raf
Academic Article Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment.
Academic Article Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF.
Academic Article Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).
Academic Article Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
Search Criteria
  • Proto Oncogene Proteins B raf
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.